Rats Prone to Obesity Under a High-Carbohydrate Diet have Increased Post-Meal CCK mRNA Expression and Characteristics of Rats Fed a High-Glycemic Index Diet by Catherine Chaumontet et al.
ORIGINAL RESEARCH
published: 09 July 2015
doi: 10.3389/fnut.2015.00022
Edited by:
Gaetano Santulli,
Columbia University, USA
Reviewed by:
Cecilia Nigro,
Institute of Experimental
Endocrinology and Oncology, Italy
Christelle Le Foll,
University of Zurich, Switzerland
*Correspondence:
Patrick C. Even,
UMR914, CRNH-IdF, AgroParisTech,
Nutrition Physiology and Ingestive
Behavior, 16 rue Claude Bernard,
Paris F-75005, France
patrick.even@agroparistech.fr
Specialty section:
This article was submitted to
Diabetes, a section of the journal
Frontiers in Nutrition
Received: 28 April 2015
Accepted: 25 June 2015
Published: 09 July 2015
Citation:
Chaumontet C, Azzout-Marniche D,
Blais A, Chalvon-Dermersay T,
Nadkarni NA, Piedcoq J,
Fromentin G, Tomé D and Even PC
(2015) Rats prone to obesity under a
high-carbohydrate diet have
increased post-meal CCK mRNA
expression and characteristics of rats
fed a high-glycemic index diet.
Front. Nutr. 2:22.
doi: 10.3389/fnut.2015.00022
Rats prone to obesity under a
high-carbohydrate diet have
increased post-meal CCK mRNA
expression and characteristics of
rats fed a high-glycemic index diet
Catherine Chaumontet1, Dalila Azzout-Marniche2, Anne Blais1,
Tristan Chalvon-Dermersay 1, Nachiket A. Nadkarni3, Julien Piedcoq1,
Gilles Fromentin1, Daniel Tomé2 and Patrick C. Even1*
1 UMR914, CRNH-IdF, INRA, Nutrition Physiology and Ingestive Behavior, Paris, France, 2 UMR914, CRNH-IdF, AgroParisTech,
Nutrition Physiology and Ingestive Behavior, Paris, France, 3 Chaire Aliment, Nutrition, Comportement Alimentaire (ANCA),
AgroParisTech, Paris, France
We previously reported that rats prone to obesity exhibit an exaggerated increase
in glucose oxidation and an exaggerated decline in lipid oxidation under a low-fat
high-carbohydrate (LF/HC) diet. The aim of the present study was to investigate the
mechanisms involved in these metabolic dysregulations. After a 1-week adaptation to
laboratory conditions, 48 male Wistar rats were fed a LF/HC diet for 3weeks. During
weeks 2 and 3, glucose tolerance tests (GTT), insulin tolerance tests (ITT), and meal
tolerance tests (MTT) were performed to evaluate blood glucose, plasma, and insulin.
Glucose and lipid oxidation were also assayed during the GTT. At the end of the study,
body composition was measured in all the rats, and they were classified as carbohydrate
resistant (CR) or carbohydrate sensitive (CS) according to their adiposity. Before sacrifice,
24 of the 48 rats received a calibrated LF/HC meal. Liver, muscle, and intestine tissue
samples were taken to measure mRNA expression of key genes involved in glucose,
lipid, and protein metabolism. ITT, GTT, and MTT showed that CS rats were neither
insulin resistant nor glucose intolerant, but mRNA expression of cholecystokinin (CCK)
in the duodenum was higher and that of CPT1, PPARα, and PGC1α in liver were lower
than in CR rats. From these results, we make the hypothesis that in CS rats, CCK
increased pancreatic secretion, which may favor a quicker absorption of carbohydrates
and consequently induces an enhanced inhibition of lipid oxidation in the liver, leading to
a progressive accumulation of fat preferentially in visceral deposits. Such a mechanism
may explain why CS rats share many characteristics observed in rats fed a high-glycemic
index diet.
Keywords: rat model, obesity prone, glucose, insulin, CCK, dietary obesity, indirect calorimetry, glucose
tolerance test
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Introduction
Large differences are observed between individuals in their capac-
ity to properly adjust substrate oxidation and energy expenditure
in order to achieve a stability of body weight and body composi-
tion in the long term. This is particularly the case in situations
of easy access to palatable energy dense foods (1–5). High-fat
(HF) diets, when compared to high-carbohydrate (HC) diets, are
more at risk to induce body weight gain because of the large
storage capacities of adipose tissue and the low satiating effects of
high fat diets, as compared to the low capacities of the glycogen
stores and of the de novo lipogenesis cost (6). Moreover, HC
diets have been proposed as a way to fight against obesity (7–
9), and recent dietary guidelines insist on reducing fat intake and
maintaining 45–65% of intake as carbohydrate based on whole
grain, vegetables, and fruits (10). However, the idea of replacing fat
with carbohydrate is now challenged by the respective quality of
fats and carbohydrates (11), insisting on the adverse effects of high
glycemic index carbohydrate on the control of food intake and on
the evolution of insulin resistance (12, 13). In this context, slowing
down the rate of glucose absorption by adding insoluble fibers to a
high sucrose diet was shown to reduce fat deposition and alleviate
the evolution of the symptoms of metabolic syndrome (14).
Previous studies have shown that feeding rats with a standard
low-fat HC starch based diet [conforming to the AIN-93 rec-
ommendations for rodents (15)], which was expected to induce
a moderate glycemic index, was able to generate differences in
adiposity gain, although partly hidden by rather small differences
in overall body weight gain (16–18). In these conditions, adiposity
does not reach the levels observed with HF diets, but the relative
differences of gain prone vs. resistant animals are as large as or
even larger than observed with HF diets. In addition, fat tends to
accumulate more viscerally than in response to HF feeding which
can have negative effects in terms of development of metabolic
syndrome. Moreover, rats prone to obesity under low-fat HC diets
[carbohydrate sensitive rats (CS)] are not necessarily fat sensitive
(FS) (meaning prone to obesity under an HF diet); in fact, only
50% are suggesting that the underlying metabolic defects lead-
ing to carbohydrate or fat sensitivity to obesity may be different
(17). Accordingly, analysis of the feeding and activity behavior of
these animals and in-depth analysis of the various components of
energy expenditure revealed that both CS and FS rats exhibit a
defective pattern of spontaneous activity when they are fed with
the diets to which they are sensitive (16, 18). Moreover, only the
CS rats reveal an exaggerated increase in glucose oxidation and an
Abbreviations:ACC, acetyl-coA carboxylase; ACOX1, peroxisomal acyl-coenzyme
A oxidase 1; BCAT2, branched chain amino-acid transaminase 2; BCKDHα, 3-
methyl-2-oxobutanoate dehydrogenase; CaD, cathepsin D; CCK, colecystockinin;
CPT1a, carnitine palmitoyltransferase 1a-liver isoform; CPT1b, carnitine palmi-
toyltransferase 1b-muscle isoform; CD36, fatty acid translocase; CR, carbohydrate
resistant; CS, carbohydrate sensitive; FAS, fatty acid synthase; FR, fat resistant; FS,
fat sensitive; GIP, glucose-dependent insulinotropic polypeptide; GK, glucokinase;
GLP-1, glucagon-like peptide-1; GTT, glucose tolerance test; HC, high carbohy-
drate; HF, high fat; HK2, hexokinase 2; ITT, insulin tolerance test; LF, low-fat; L-PK,
liver-pyruvate kinase; MTT, meal tolerance test; PGC1α, peroxisome proliferator-
activated receptor gamma coactivator 1-alpha; PPARα, peroxisome proliferator-
activated receptor alpha; PYY, peptideYY; UBE2B, ubiquitin-conjugating enzyme
E2B.
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FIGURE 1 |Meal-induced changes in glucose and lipid oxidation after
ingestion of a low-fat high carbohydrate test meal in CR and CS rats.
This figure has been drawn with data taken from the experiment previously
published in Nadkarni et al. (17).
exaggerated decline in lipid oxidation in response to an HC meal
(Figure 1) (17). In the longterm, such a response could explain the
progressive accumulation of fat in CS rats.
The goal of the present study was to identify the mechanisms
responsible for the exaggerated meal-induced changes in glucose
and lipid oxidation in CS rats. It was hypothesized that in these
CS rats, the insulin response to feeding and/or the sensitivity
to insulin is greater than in carbohydrate resistant (CR) ones.
To that purpose, Wistar rats were submitted for 3weeks to HC
feeding, during which their response to glucose, meal, and insulin
tolerance tests were measured. At the end of the study, muscle,
liver, and intestine were sampled for quantification of mRNA
expression 2 h after ingestion of a calibrated test-meal.
Materials and Methods
Experimental Procedure
The study was approved by the French National Animal Care
Committee (number 12/098) and conformed to the European
legislation on the use of laboratory animals. Forty-eight male
Wistar rats were ordered at 7weeks of age (Harlan) and were
delivered in groups of eight at 2-week intervals. They initially
weighed 229.8 1.5 g. All the rats were submitted to the same
dietary procedure: after a 1-week adaptation to laboratory condi-
tions (temperature 22°C 1, humidity 60%, 12/12 L/D cycle lights
on at 08:00), during which they were fed a standard laboratory
chow (A04, SAFE, France), they were switched to a semi-synthetic
LF/HC diet for a 3-week period (UPAE, INRA, Joey-en-Josas,
France). It is important to note that this diet was close inmacronu-
trient composition to the standard A04 diet and conformed to
the AIN-93 recommendations (Table 1), and therefore that the
rats were not submitted to significant changes in the macronu-
trient composition of their diet during the study. The use of this
semi-synthetic diet allowed us to closely control and secure the
stability of the origin of the macronutrient sources throughout
the study.
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TABLE 1 |Macronutrient composition of the diet.
HCD
Weight content (g/kg)
Milk proteins 140:0
Starch 622:4
Sucrose 100:3
Soy Oil 40:0
Minerals 35:0
Vitamins 10:0
Cellulose 50:0
Choline 2:3
Energy content (%)
Protein 14:7
Carbohydrate 75:9
Fat 9:4
Energy density (kJ/g) 15:95
Food quotient 0:946
The diet was prepared by the “atelier de préparation des aliments,” UPAE, INRA, Jouy-
en-Josas, France. Energy density is computed assuming a metabolizable energy of
16.7 kJ/g for carbohydrates and proteins, and 37.7 kJ/g for fat. Food quotient is computed
assuming a quotient of oxidation of 1.0 for carbohydrates, 0.825 for proteins, and 0.70 for
lipids.
At the end of the 3weeks of regimen, the rats were killed
and their body composition precisely measured by dissection and
weighing of the main organs and tissues.
In the first three groups (n= 24, initial weight 231.7 2.1 g,
final weight 338.1 7.2 g), a glucose tolerance test (GTT) and
an insulin tolerance test (ITT) were performed in random order
during the second and third week of the regimen (only one test in
eachweek). TheGTTwas performed in 6 h-fasted rats as indicated
for a standard GTT, and ITT was performed on fed rats. In 15 of
these 24 rats, respiratory exchanges in response to a GTT were
also followed by indirect calorimetry. At least, 1 week of washout
was ensured between the two tests in the rats that underwent the
two procedures. In the last three groups (n= 23, initial weight
228.8 2.1 g, final weight 316.3 4.2 g), a 60 kJ meal tolerance
test (MTT) of the regimen was performed during the second or
third week of the regimen. The MTT was performed after an
overnight fast to ensure that the rats ingested the test meal within
30min after presentation.
Glucose and Insulin Response to GTT, ITT,
and MTT
For GTT, food was removed at 08:00 in the morning. Glucose
1.5 g/kg (solution 0.25 g/ml) was injected i.p. at 14:30 and blood
samples (200µl) were taken from the tail vein ~15min before
(t0), then 10, 20, 30, 60, 90, and 120min after injection. For ITT,
insulin 0.3U/kg dissolved in 1ml 0.9% NaCl was injected in fed
rats at 14:00. Blood samples were taken from the tail vein before
(t0), then at 10, 20, 30, 60, and 90min after injection. For MTT,
rats were fasted overnight. A calibrated test-meal (60 kJ) of the
diet was given to the rat at 10:00, and it was visually controlled
that the rats ingested the meal within 30min. Blood was taken
from the tail vein ~15min before (t0), then at 60, 120, 180, 240,
and 300min after meal onset. In all studies, glucose was immedi-
ately assayed using a standard glucometer (Life-scan, One touch
Vita). Blood was centrifuged (10min, 3000 g, 4°C) and plasma
stored at  20°C for subsequent assay of insulin. Plasma insulin
was detected using enzyme linked immunoassay (Mercodia Rat
Insulin, ELISA).
Changes in the Rates of Glucose and Lipid
Oxidation in Response to GTT
The rats were housed in a calorimetry cage at 18:00 and were
fasted overnight while in the calorimetry cage.Water was available
throughout. Recording of respiratory exchanges was immediately
started. The next day at 10:00, the rats received 1.5 g/kg glucose
i.p. and were immediately returned to the metabolic cage.
Measurements of respiratory exchanges were continued until
17:00. Glucose oxidation (Gox) and lipid oxidation (Lox) were
computed from resting oxygen and carbon dioxide consumption
(VO2 and VCO2) with the following formula (19): Gox (Watts)=
[(4.57 *VCO2)–(3.23 *VO2)] * (15.6/60), Lox (Watts)= [(1.69 *
VO2)–(1.69 *VCO2)] * (39.5/60), with VO2 and VCO2 in
mL/min, 15.6= kJ/g for glucose, 39.5= kJ/g for lipids. Division
by 60 is to convert Joules/min into Joules/second=Watts.
For a detailed description of the calorimetry procedures, see
Ref. (19).
Euthanasia, Tissue Collection, and Segregation
Between CR and CS Rats
Euthanasia was performed at the end of the third week of reg-
imen by i.p. injection of an overdose (60mg/kg) of sodium
pentobarbital. Body composition was assessed by dissection and
weighing of the main organs and tissues (liver, spleen, car-
cass, pancreas, subcutaneous, epididymal, retroperitoneal and
mesenteric adipose tissues, skin, heart, scapular brown adipose
tissue). In order to perform an objective segregation between
CR and CS rats, we used the Student’s confidence interval of
the final adiposity values (fat weight/body weight) of the rats
computed at the 1% level with Excel. Mean observed adipos-
ity was 9.57% with a standard deviation (SD) of 2.12% and a
Student’s confidence interval (SCI) of 0.831%. We thus classi-
fied as CR the rats with an adiposity below 8.74% (Mean–SCI)
(n= 13), and as CS the rats with an adiposity above 10.40%
(Mean+ SCI) (n= 18). The other rats (n= 16) were removed
from data analysis.
For analysis ofmRNA expression in the liver, muscle, and intes-
tine, the nutritional status of the 23 rats of the last three groupswas
normalized by an overnight food deprivation followed by a 60 kJ
meal given 2 h before euthanasia. Euthanasia was performed by
decapitation after gas anesthesia with isoflurane (3% in 2 L/min).
For analysis of mRNA expression, pieces of liver, gastrocnemius
muscle, and intestine were rapidly collected and frozen in liquid
nitrogen. Trunk blood and liver sampleswere also collected for TG
content determination. Intestinal mucus of duodenum, jejunum,
and ileum were collected as follows: after dissection of the pan-
creas and mesenteric adipose tissues, the intestine was rapidly
removed and separated into three parts (duodenum, jejunum, and
ileum). The pieces of intestine were flushed with sterile PBS, and
epithelial cells were collected by scraping on ice, placed inTRIzol®,
and frozen in liquid nitrogen. After thawing, cells were disrupted
with a needle.
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Gene Expression Profile Measurement
RNA preparation and gene expression measurement
Total RNA was extracted using TRIzol® reagent (Invitrogen,
Carlsbad, CA, USA). RNA concentration was assessed using a
nanodrop spectrophotometer at 260 nm and RNA integrity was
confirmed by electrophoresis on agarose gel. Retrotransciption
was performed on 0.4µg of RNA for muscle and liver or on 10µg
of RNA for intestine to synthetize cDNA using High Capacity
cDNA Archive Kit Protocol (Applied Biosystems).
Real Time PCR was performed to measure gene expression on
an ABI 7300 (Applied Biosystems) using Power SYBR GREEN
PCR MIX (Applied Biosystems). The primer sequences of
genes were designed with Primer Express software and the
sequence of each primer is given in Table 2. We studied mRNA
encoding proteins involved in metabolism such as glycolysis
[Glucokinase (GK), Liver-pyruvate kinase (L-PK), Hexokinase
2(HK2)]; lipogenesis [Acetyl-coA carboxylase (ACC), Fatty
acid synthase (FAS)]; fatty acid oxidation (Peroxisomal acyl-
coenzyme A oxidase 1 (ACOX1), Carnitine palmitoyltransferase
1a-liver isoform (CPT1a), Carnitine palmitoyltransferase
1b-muscle isoform (CPT1b), Fatty acid translocase (CD36),
Peroxisome proliferator-activated receptor gamma coactivator
1-alpha (PGC1α), Peroxisome proliferator-activated receptor
alpha (PPARα); branched-chain amino acid metabolism
[branched chain amino-acid transaminase 2 (BCAT2), 3-
methyl-2-oxobutanoate dehydrogenase (BCKDH)]; proteolysis
[Ubiquitin-conjugating enzyme E2B (UBE2B), Cathepsin
D (CaD)]. For intestine, we studied the expression of the
anorexigenic gut peptides cholecystokinin (CCK), peptide YY
(PYY), glucagon-like peptide-1 (GLP-1), and glucose-dependent
insulinotropic polypeptide (GIP) in the different sections of
intestine.
RT-PCR was performed using 10 ng (5µl) of cDNA for liver,
muscle, or adipose tissue, and 250 ng (5µl) of cDNA for intestine
in addition to 15µl of the reagent mix containing RNAase free
water, PCR Mix plus forward and reverse primers as previously
described (21). The threshold (CT) was set with the constant
value for all of the genes and samples to quantify the mRNA
concentration, and gene expression was calculated as: 2 ∆CT,
where ∆CT=CT Gene – CT 18S. Data are means SE expressed
as a percentage of the values of the CR rats. Negative controls
were used to detect potential contamination (control without RT
or RNA).
Statistical Analysis
47 of the 48 rats completed the study. In addition, rat 43, whichwas
the fattest one (adiposity 15.87%) with a very high subcutaneous
fat deposition and plasma TG values below mean  2SD, and rat
30, (adiposity 7.99%, would have qualified as CS) with liver and
plasma TG values above mean+ 2SD, were excluded from the
study.
Results are reported as mean SEM. Between group com-
parisons were done by Student’s t-tests in Excel. Changes
in blood glucose and plasma insulin induced by the GTT,
ITT, and MTT were analyzed by ANOVA with Statgraphics®
V5.1. Differences with P-values below 0.05 were considered as
significant.
TABLE 2 | Primer sequences used for liver, muscle, adipose tissue, and
intestine mRNA analysis.
Gene Sequence
GK forward 50-TTGAGACCCGTTTCGTGTCA – 30
reverse 50-AGGGTCGAAGCCCCAGAGT -30
L-PK forward 50-TGATGATTGGACGCTGCAA – 30
reverse 50-GAGTTGGTCGAGCCTTAGTGATC – 30
HK2 forward 50-AACCGAACAAGCTGGTGTAC-30
reverse 50-TGCACACATCTATAGGTGGC-30
ACC forward 50-CAACGCCTTCACACCACCTT -30
reverse 50-AGCCCATTACTTCATCAAAGATCCT -30
FAS forward 50-TGCTCCCAGCTGCAG -30
reverse 50-GCCCGGTAGCTCTGGGTGTA -30
ACOX1 forward 50-AAGAAATCCCCACTGAACAAAACA -30
reverse 50-CCCAGGGAAACTTCAAAGCTT -30
CPT1a forward 50-ATATCAAGGACAGCAGGCACAT -30
reverse 50-CTCAGCAGCCTCCCATGCT -30
CPT1 b forward 50-CAGCCATGCCACCAAGATC -30
reverse 50-CTTGGGCAGTGATGTTTGGA -30
CD36 forward 50-CAGCCTCCTTTCCACCTTTTG-30
reverse 50-AAGGCGTTGGCTGGAAGAA-30
PGC1α forward 50-ATACCGCAAAGAGCACGAGAAG-30
reverse 50-CTCAAGAGCAGCGAAAGCGTCACAG-30
PPARα forward 50-GGGATGAAGAGGGCTGAGC-30
reverse 50-TGATTAACATTGGGCCGGTT-30
BCAT2 forward 50-GGCGGACCCTTCATTCGT-30
reverse 50-TTCCCCCCCAACTTGCA-30
BCKDHα forward 50-CCAGGGTTGGTGGGATGAG-30
reverse 50-GGCTTCCATGACCTTCTTTCG-30
UBE2B forward 50-AACGCAGTTATATTTGGACCAGAAG-30
reverse 50-ACGGTTGGTGGTTTATTTGGAT-30
CAD forward 50-CGCAGTGTTTCACAGTCGTCTT-30
reverse 50-TGGACTTGTCACTGTTGTACTTATGG-30
CCK forward 50-CAGGTCCGCAAAGCTCCTT30
reverse 50-TCCAGGCTCTGCAGGTTCTT-30
PYY forward 50-CGGCAGCGGTATGGAAAA-30
reverse 50-TGTGAAGAGCAGTTTGGAGAACA-30
GLP-1 forward 50-CTCCCGCCGTGCTCAA-30
reverse 50-TTGTTCCGGTTCCTCTTGGT-30
GIP forward 50-CTGCTGGTGCTCCTGTTCCT-30
reverse 50-CATGGGATCGGAACTCAACCT-30
The forward and reverse primers were designed using primer express software (Applied
Biosystems). The following abbreviations are used: GK, glucokinase; L-PK, liver-pyruvate
kinase; HK2, hexokinase 2; ACC, acetyl-coA carboxylase; fatty acid synthase (20);
ACOX1, peroxisomal acyl-coenzyme A oxidase 1; CPT1a, carnitine palmitoyltransferase
1a-liver isoform; CPT1b, carnitine palmitoyltransferase 1b-muscle isoform; CD36, fatty
acid translocase; PGC1α, peroxisome proliferator-activated receptor gamma coactivator
1-alpha; PPARα, peroxisome proliferator-activated receptor alpha; BCAT2, branched
chain amino-acid transaminase 2; BCKDHα, 3-methyl-2-oxobutanoate dehydrogenase;
UBE2B, ubiquitin-conjugating enzyme E2B; CaD, cathepsin D; CCK, colecystockinin;
PYY, peptide YY; GLP-1, glucagon-like Peptide-1; GIP, glucose-dependent insulinotropic
polypeptide.
Results
Body Weight and Body Composition
The main elements of body composition are given in Table 3.
CS and CR rats had similar BW at the onset of the study. At the
end, CS rats were significant but only 9.6% heavier than CR rats.
Evolution of BW during the study (Figure 2) indeed showed that
Frontiers in Nutrition | www.frontiersin.org July 2015 | Volume 2 | Article 224
Chaumontet et al. Metabolic characteristics of carbohydrate sensitive rats
TABLE 3 | Body composition of the CR and CS rats (data in g except
otherwise stated).
CR (MeanSEM) CS (MeanSEM) P
Init weight 230:7 2:0 232:0 2:5 0.726
Final weight 310:4 5:0 340:5 7:9 0.006
Delta weight 79:7 4:1 108:42 6:2 0.001
Carcass 143:2 2:7 146:9 3:4 0.417
Skin 52:5 0:9 57:8 3:3 0.018
Total fat 21:78 0:80 39:92 1:41 <10 11
Subcutaneous 9:37 0:63 16:00 0:61 <10 7
Mesenteric 2:53 0:16 4:74 0:18 <10 8
Epidydimal 4:82 0:24 8:23 0:49 <10 5
Retroperitoneal 5:05 0:30 9:85 0:55 <10 6
Adiposity (%)a 7:03 0:27 11:39 0:15 <10 14
Ratio visc/subcb 1:39 0:11 1:47 0:10 0.602
LBM 209:3 3:3 220:0 5:0 0.110
Liver 8:54 0:28 10:20 0:39 0.004
Spleen 0:583 0:016 0:618 0:016 0.142
Heart 0:727 0:014 0:769 0:018 0.091
kidneys 2:01 0:05 2:13 0:06 0.178
Testis 3:46 0:12 3:66 0:17 0.377
Pancreas 1:08 0:06 1:05 0:06 0.728
Scapular BATc 0:600 0:040 0:683 0:027 0.083
Adrenals 0:062 0:003 0:060 0:004 0.659
aAdiposity= total fat mass/body weight * 100.
b(Epipidymal+ retroperitoneal+mesenteric fat)/subcutaneous fat.
cBAT, brown adipose tissue.
FIGURE 2 | Evolution of body weight: CR and CS rats had similar body
weight at the onset of the study. Differences developed slowly and did not
become significant before 21 days (at the time rats were ~10weeks old).
differences in BWbetweenCS andCR rats became significant only
after 21 days of the regimen. Lean body mass (LBM) and carcass
mass were not different but CS rats had much larger masses of all
the adipose tissues and greater adiposity levels (+62%). The ratio
of visceral to subcutaneous fat was not lower in CS than in CR
rats, indicating that excess fat mass accumulated in the viscera as
much as subcutaneously. Among the organs, only liver weight was
significantly increased in CS rats.
Blood Glucose and Plasma Insulin Responses to
Glucose, Insulin, and Meal Tolerance Tests
GTT and ITT were performed on the 24 rats of the three
first groups, among which six were a posteriori classified as
TABLE 4 | Basal blood glucose (mmol/L), plasma insulin (nmol/L), and
HOMA index {[glucose (mmol/L) insulin (pmol/L)]/22.5} at the onset of the
glucose and meal tolerance tests.
CR (MeanSEM) CS (MeanSEM) P
Onset of GTT
Glucose 4:62 0:32 5:21 0:27 0.223
Insulin 0:366 0:024 0:483 0:032 0.013
HOMA 37:9 4:18 57:5 5:90 0.041
Onset of MTT
Glucose 4:70 0:26 5:01 0:21 0.372
Insulin 0:132 0:013 0:219 0:049 0.132
HOMA 14:4 2:08 23:7 4:36 0.088
CR (final adiposity 7.22 0.28%) and 10 as CS (final adiposity
11.60 0.21%). MTT were performed on the 24 rats of the last
three groups, among which eight were a posteriori classified as
CR (final adiposity 7.00 0.41%) and eight as CS (final adiposity
11.82 0.60%).
Insulin levels and HOMA indices were higher in CS rats
(Table 4) before the GTT, i.e., after 6 h fast, but not before the
MTT, i.e., after an overnight fast. Figure 3 displays the glucose
and insulin responses to GTT, ITT, and MTT. The decline in
plasma glucose after ITT (Figure 3C) did not reveal differences
between CR and CS rats, indicating that CS rats were not resistant
to the hypoglycemic effect of insulin. Glucose and insulin levels
during GTT were significantly higher in CS than in CR rats
(Figure 3A). During MTT, only insulin levels were significantly
higher (Figure 3B). Areas under the curve were significantly
different only for the insulin response to GTT. When basal blood
glucose or plasma insulin values were introduced as a covariate in
the ANOVA, no more differences were observed between groups,
indicating that differences during GTT and MTT were due to
preexisting differences in basal glucose and insulin levels.
Changes in Glucose and Lipid Oxidation in
Response to GTT
Changes in glucose and lipid oxidation in response to GTT were
measured by indirect calorimetry on 15 rats, among which four
were a posteriori classified as CR (final adiposity 6.53 0.44%)
and six as CS (final adiposity 11.26 0.2%). The GTT induced
an increase in glucose oxidation that peaked between 30 and
60min, then returned to basal levels within 120min (Figure 4),
a kinetic that closely paralleled the changes observed in blood
glucose (Figure 3). Changes in Lox mirrored the changes in Gox
but were of smaller amplitude and duration.
Postprandial Expression Profile of Genes Involved in
Metabolism in Liver, Muscle, and Intestine 2 h After
Ingestion of a Test-Meal
Genes involved in glucose oxidation and de novo
lipogenesis
In the liver (Figure 5A), GK gene expression was 40% lower
in CS rats, suggesting that glycolysis may be reduced, but gene
expression of L-PK situated downstream of GK was not different.
On the other hand, expression of genes involved in lipogenesis
such as ACC FAS did not differ between CS and CR rats. Taken
together, these results suggest that the control of glycolysis and
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lipogenesis in liver did not differ significantly between CR and
CS rats.
In muscle, no significant changes were observed for HK2, the
first enzyme of glycolysis (Figure 5B).
Genes involved in lipid oxidation
In the liver (Figure 5A), expression of PGC1α (a transcriptional
coactivator regulating genes involved in energymetabolism and in
particularmitochondrial biogenetics) was twice as high inCR rats.
Expression of PPARα (a transcription factor and key regulator
of genes involved in multiple processes of lipid metabolism) also
tended to be higher in CR rats than in CS rats (P< 0.08). In turn,
mRNA encoding CPT1a (which is under the control of PPARα
and PGC1α (22) and controls the transfer of long-chain fatty acyl
CoA into mitochondria) was 2.5-fold greater in CR rats. Other
genes involved in fatty acid oxidation in liver, such as ACOX1 and
CD36, were unchanged. These results suggest that CS rats exhibit
a lower potential for fatty acid oxidation in liver.
In muscle (Figure 5B), no difference was observed for the
expression of genes involved in the control of fatty acid oxidation
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as indicated by lack of differences in the expression of PGC1α
and CPT1b.
Branched-chain amino acid metabolism and proteolysis
in muscle
We observed no difference in the expression of genes involved in
proteolysis (CAD and UBE2B) and BCAA metabolism (BCAT2
and BCKDH) in muscle (Figure 5B).
Gene expression in the duodenum, jejunum, and ileum
mRNA expression of CCK was larger in duodenum and jejunum
of CS rats but significant only in duodenum (Figure 5C). No
differences were observed in themRNA expression of GLP1, PYY,
and GIP.
TG in Blood and Liver
Plasma TG measured 2 h after ingestion of a 60 kJ test meal was
significantly higher in CS rats [mmol/L: 2.46 0.13 (n= 7) vs.
2.015 0.13 (n= 7), P= 0.03) as was liver TG (mg/g: 13.23 0.52
(n= 7) vs. 11.19 0.39 (n= 7), P< 0.01]. There was also a sig-
nificant correlation between liver TG and adiposity (R2= 0.59,
n= 14, P< 0.01), plasma TG and adiposity (R2= 0.457, n= 14,
P< 0.01), and plasma TG and liver TG (R2= 0.561, n= 14,
P< 0.01).
Discussion
The main goal of this study was to investigate the mechanisms
contributing to the exaggerated increase in glucose oxidation
together with an exaggerated decrease in lipid oxidation observed
after ingestion of an HC test-meal in CS rats (17). These changes
were suspected to support the progressive increase of fat mass in
CS rats. Our initial hypothesis was that CS rats could be more
sensitive to insulin and/or produce more insulin in response to
ingestion of a high carbohydrate meal.
In this study,Wistar rats were fed a standard high-carbohydrate
low-fat diet designed according to the AIN93 recommendations
(15), in which most of the carbohydrate was provided as starch,
and was thus expected to have a moderate glycemic index. Mea-
surements were performed very early, between 2 and 3weeks after
the onset of feeding with the experimental diet, because the goal
was to search for mechanisms that may be responsible for, and not
derive from, the experimentally induced changes in body weight
and body composition.
Analysis of body weight and body composition confirmed pre-
vious reports that CS rats can hardly be discriminated from their
body weight gain (16, 17); at the end of the study, CS rats weighed
only 9% more than the CR ones. Furthermore, LBM was not
significantly different between the two groups. In contrast, total fat
was 82% greater and rather evenly distributed between the subcu-
taneous (+76.5%), mesenteric (+83%), epididymal (+67%), and
retroperitoneal (+93%) depots. From unpublishedMRI measure-
ments collected in similar conditions, we extracted a group of
12 rats weighing the same weight (232.1 1.8 g), as the rats of
this study at the onset of the experiment, and observed that in
these rats, fat mass amounted from 9.6 to 18.7 g (13.8 0.87 g).
From this data, it can be estimated that during the 3weeks of the
study, CS rats accumulated about three times more fat than CR
ones. Among the organs, only liver weight increased significantly
but the increased TG content was far too small to explain this
difference.
The phenotype of the CS rat is different from that of FS rats
[in which the increase in body weight gain and fat mass is much
higher, both fat and LBMmasses are increased, subcutaneous adi-
pose tissue expands more than visceral, and there is no difference
in liver TG content after 3 weeks of HF feeding (18)]. All these
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differences suggest that the mechanisms responsible for the accu-
mulation of fat are different in CS and FS rats. We also previously
reported that contrary to FS rats, CS rats are not hyperphagic but
display increased rates of glucose oxidation and decreased rates of
in lipid oxidation after ingestion of a high carbohydrate meal (17).
In CS rats, the early increase in liver TG, the correlation of plasma
and liver TG with adiposity levels, and the high proportion of fat
stored viscerally suggest that the primary metabolic defect may
come from an increased conversion of lipids into TG in the liver.
Since visceral fat is more diabetogenic than subcutaneous fat, this
may induce the development of insulin resistance and metabolic
syndrome at lower adiposity levels than with HF diets (23, 24).
The clinical implications of these observations are important,
since obesity is often associated with consumption of diets too
high in fat, and strategies most often orient patients toward the
consumption of a diet higher in carbohydrate. Considering the
possibility that some individualsmay react negatively to diets high
in carbohydrate because of an accelerated absorption of glucose,
such a systematic strategy should be reconsidered in particular in
patients with visceral obesity. The results of this study need to be
confirmed and completed; the mechanisms possibly responsible
for an accelerated rate of glucose absorption suggested by the
results of the present study should be investigated, in particular
the essential functions of the endocrine and exocrine pancreas in
which, for example, mutant leaky type2 ryanodine receptors lead
to impaired glucose homeostasis and decreased fuel-stimulated
insulin release (25).
The similarity of the decrease in blood glucose after insulin
injection during the ITT clearly indicates that CS rats are as
sensitive as CR ones to the glucose-lowering effect of insulin, and
thus are not resistant to insulin. On the other hand, we observed
that plasma insulin and the HOMA index were higher in the
CS rats before the GTT after the rats were fasted 6 h, but the
differences were much reduced and no more significant before
the MTT after the rats were fasted overnight. Taken together with
the results of the ITT, these insulin levels and HOMA indices
suggest that plasma insulin, and to a lesser extent, blood glucose
levels, decrease more slowly in CS than in CR rats but that CS
rats still did not suffer significant insulin resistance at the time of
the study. Differences were also observed in glucose and insulin
values after the GTT and MTT. However, these differences were
primarily due to preexisting differences in the basal state before
the tests: if, rather than absolute levels, one considers the ampli-
tudes of the glucose and insulin response, they were similar in
CR and CS rats. In addition, using indirect calorimetry, we did
not observe significant differences in the changes in glucose and
lipid oxidation induced by theGTT. This lack of difference sharply
contrasts with the large and very significant differences in Gox
and Lox previously reported in response to ingestion of a meal-
test (17). The reason for this difference possibly has its roots in
the amount and rate of delivery of energy induced by the GTT
and the MTT, and therefore the respective role of the liver and
peripheral tissues in the handling of the caloric load: the early
and large increase in peripheral blood glucose after the GTT indi-
cated that much glucose escaped metabolism by the liver and was
probably oxidized peripherally by muscles. Accordingly, indirect
calorimetry showed that over 3 h, the GTT increased Gox but did
not significantly affect Lox (Figure 4), suggestive of an uncoupling
between the respective rates of Gox and Lox as expected if glucose
oxidation had occurred in the liver. By contrast, after theMTT, we
observed that peripheral blood glucose increased much less and
we previously reported that the decrease in lipid oxidation quite
mirrored the increase in glucose oxidation (Figure 1), indicating
that the handling of the glucose derived from the meals occurred
primarily in the liver (17). The similarity of changes in glucose and
lipid oxidation in CR andCS rats after theGTT, where glucose was
directly injected in the abdominal cavity, and the differences after
ingestion of the meals, where most of the glucose was produced
by the degradation of ingested starch, suggest that the differences
in post-meal rates of glucose and lipid oxidation between CR and
CS rats depend on initial differences in the degradation of starch
in the intestine and/or in differences in the speed of absorption of
glucose by the intestine.
mRNA expression of genes coding for enzymes involved in
glucose and lipid metabolism in liver may depict a possible mech-
anism to explain the increased Gox and decreased Lox in CS rats
after a MTT. We indeed observed that in liver, 2 h after ingestion
of the calibrated test-meal, mRNA expression of several enzymes
involved in fatty acid oxidation, such CPT1, PPARα, and PGC1α,
was lower in CS rats, suggesting that at this time lipid oxidation
may be lower in CS rats as observed in vivo by indirect calorimetry
(17). By contrast, no differences were observed in mRNA encod-
ing genes involved in lipogenesis, i.e., FAS and ACC, but this lack
of response may also be due to the fact that measurements were
performed exactly 2 h after ingestion of the test-meal, so at a time
when glycogen stores were still not fully restored. Indeed, hepatic
lipogenesis is under the control of a complex system and can be
stimulated only when there is substrate availability and glycogen
stores have been replenished (26). However, liver and plasma TG
measured 2 h after ingestion of the MTT were greater in CS rats
and generally correlated with adiposity, which suggest that lipid
synthesis was higher in the liver of CS rats. Assuming that the
CS rats were not insulin-resistant, their small but regularly higher
insulin levels may have reduced the expression of liver mRNA
encoding proteins involved in fatty acid oxidation, thus reduced
lipid oxidation and favored TG release in the blood and accumu-
lation in the liver. In muscle, the enzymes involved in the control
of protein, glucose, and lipid metabolism were not affected, which
agrees with the fact that we observed no differences in Gox and
Lox after the GTT that induced large changes in peripheral blood
glucose. This also agrees with the fact that we previously observed
no differences in the meal-induced changes in the respiratory
quotient of working muscles (17). Taken together, these results
suggest that in CS rats, the primary mechanism responsible for
the increased adiposity may be an insulin-induced exaggerated
decrease in the rate of lipid oxidation by the liver, which makes
more free fatty acids (FFA) available for TG synthesis and storage
in the liver and visceral adipose tissues.
The higher insulin levels in CS rats in the basal state as well as in
response to the GTT andMTT could be related, at least for a part,
to the significantly higher expression of intestinal CCK mRNA
that may reflect increased CCK release. Protein and fat (27–
29) and to a lesser extent carbohydrates (30, 31) stimulate CCK
release. Each of these hormones enhances insulin secretion and
improves glucose tolerance. Both CCK-8 and CCK-32 are potent
stimuli for insulin release as measured in vitro and in animal
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models (32, 33). In addition, CCK stimulates secretion of digestive
enzymes by the pancreas, among which amylase, which may favor
an accelerated degradation of starch and absorption of glucose by
the intestine. Therefore, even with starch-based diets, such rats
may evolve as if maintained on a higher glycemic index (GI) diet
compared to CR rats. At the rather young age when they were
studied (10weeks old), the rats still responded normally to insulin
but fasting insulin levels and HOMA indices already tended to be
increased. Thus in the long-term, it is possible that CS rats could
develop significant insulin resistance and glucose intolerance as
observed in rats fed a high GI diet. By contrast, it was previously
reported that impaired lipid oxidation in response to high GI
diets occurs before development of impaired insulin secretion
and insulin resistance (34), which was indeed the case in the rats
of this study and was also suggested by the more pronounced
decrease in whole body lipid oxidation reported previously (17).
Rats and mice fed low-fat high GI diets are not hyperphagic,
do not gain more weight, or only marginally more, but accumu-
late more fat and predominantly more visceral fat (35–37). They
develop insulin resistance without impaired glucose tolerance
within 8–12weeks (13, 35), and in the longer term, 8–52weeks,
exhibit higher basal insulin levels and impaired glucose tolerance
(35, 36, 38, 39). Results on bloodTG are contradictory; higher (38)
on a high GI low-fat diet or lower (13) on a 30% fat Western type
diet, but liver TG is consistently increased. All these characteristics
fit withwhatwe observed in theCS rats in the present andprevious
studies, and may be responsible for the cascade of events finally
leading to the sensitivity to obesity of CS rats fed a standard
high-carbohydrate diet.
Conclusion
The CS rat model shows that obesity is not necessarily dependent
upon high-fat feeding and/or overfeeding. This study points to the
possible involvement of an exaggeratedCCK response to ingestion
of an HC diet possibly responsible for an accelerated degradation
of starch in the intestine and increased delivery of glucose into
the blood leading CS rats to reduce fat oxidation in the liver
and progressively develop insulin resistance and visceral obesity
in a process similar to the one observed in rats fed a high GI
diet. The consistency of the CS rat model and the observation
that such a form of obesity also seems to occur in the mouse
model (40) suggest that this phenotype may also be observed
in humans. If the hypotheses raised here are confirmed, one
should consider extending this research into humans. As recently
described to diagnose lactose intolerance in the rat model than
in humans (41, 42), measurements of changes in glucose and
lipid oxidation in response to ingestion of a high-carbohydrate
meal should be considered as a non-invasive test to assess in
humans the predisposition to gain excess fat with a low-fat high-
carbohydrate regimen.
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